Abstract
9-Methylene- and 9-ethylidene-5-(m-methoxyphenyl)-2-methylmorphans (1, 2) and refluxing 48% HBr have given rearrangement products 3 and 4, respectively. The structure of 4 [4a-ethyl-2,4a,5,6,7,7a-hexahydro-4-(3-hydroxyphenyl)-1-methyl-1H-1- pyrindine] was determined by X-ray crystallography and that of 3 [1,4a-dimethyl-2,4a,5,6,7,7a-hexahydro-4-(3-hydroxyphenyl)-1-methyl-1H- pyrindine] follows from analogy and NMR data. Compounds 3 and 4 are opioid antagonists of about the potency of nalorphine in the tail-flick vs. morphine assay and precipitate a complete abstinence syndrome in morphine-dependent monkeys. Both are nearly devoid of antinociceptive activity and they have about 0.025 times the affinity of nalorphine for the mu opioid receptor.
Publication types
-
Comparative Study
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Alkaloids / metabolism
-
Alkaloids / pharmacology*
-
Analgesia
-
Animals
-
Chemical Phenomena
-
Chemistry
-
Macaca mulatta
-
Male
-
Mice
-
Morphine / antagonists & inhibitors
-
Nalorphine / metabolism
-
Nalorphine / pharmacology
-
Naloxone / pharmacology
-
Narcotic Antagonists*
-
Pyridines*
-
Rats
-
Rats, Inbred Strains
-
Receptors, Opioid / metabolism
-
Receptors, Opioid, mu
-
Sodium / pharmacology
-
X-Ray Diffraction
Substances
-
Alkaloids
-
Narcotic Antagonists
-
Pyridines
-
Receptors, Opioid
-
Receptors, Opioid, mu
-
1,4a-dimethyl-2,4a,5,6,7,7a-hexahydro-4-(3-hydroxyphenyl)-1-methyl-1H-1-pyrindine
-
4a-ethyl-2,4a,5,6,7,7a-hexahydro-4-(3-hydroxyphenyl)-1-methyl-1H-1-pyrindine
-
Naloxone
-
Morphine
-
Sodium
-
Nalorphine